RESUMO
Cartilage regeneration using biomaterial-guided delivery systems presents improved therapeutic efficacy of the biomolecules while minimizing side effects. Here, our hypothesis was to design a multilayer scaffold of chitosan (CS) hydrogel and polycaprolactone (PCL) mat to enhance the mechanical properties, integrity and stability of CS, especially for subsequent in vivo transplantation. After conjugation of the Kartogenin (KGN) into this structure, its gradual release can promote chondrogenesis of mesenchymal stem cells (MSCs). Initially, a thin electrospun PCL layer was sandwiched between two CS hydrogels. Subsequently, KGN was superficially immobilized onto the CS matrix. The successful conjugation was confirmed by scanning electron microscopy (SEM) and infrared spectroscopy. These novel KGN-conjugated scaffolds possessed lower swelling and higher compressive modulus and showed gradual release of KGN in longer retention times. Immunofluorescent and histological staining represented more cells located in lacunae as well as more Coll2 and Sox9 positive cells on KGN-conjugated scaffolds. Gene expression analysis also revealed that SOX9, COLL2 and ACAN expression levels were higher in the presence of KGN, while COLLX expression was down-regulated, indicating a hypertrophy phenomenon with synergistic effect of TGF-ß. This multilayer structure not only facilitates the effective treatment, but also provides a proper mechanical structure for cartilage engineering.
Assuntos
Cartilagem/fisiologia , Quitosana , Condrócitos/metabolismo , Preparações de Ação Retardada , Poliésteres , Regeneração/efeitos dos fármacos , Anilidas/química , Anilidas/farmacocinética , Anilidas/farmacologia , Células Cultivadas , Quitosana/química , Quitosana/farmacologia , Humanos , Ácidos Ftálicos/química , Ácidos Ftálicos/farmacocinética , Ácidos Ftálicos/farmacologia , Poliésteres/química , Poliésteres/farmacologiaRESUMO
Electrospinning is a valuable technology for cartilage tissue engineering (CTE) due to its ability to produce fibrous scaffolds mimicking the nanoscale and alignment of collagen fibers present within the superficial zone of articular cartilage. Coaxial electrospinning allows the fabrication of core-shell fibers able to incorporate and release bioactive molecules (e.g., drugs or growth factors) in a controlled manner. Herein, we used coaxial electrospinning to produce coaxial poly(glycerol sebacate) (PGS)/poly(caprolactone) (PCL) aligned nanofibers (core:PGS/shell:PCL). The obtained scaffolds were characterized in terms of their structure, chemical composition, thermal properties, mechanical performance and in vitro degradation kinetics, in comparison to monoaxial PCL aligned fibers and respective non-aligned controls. All the electrospun scaffolds produced presented average fiber diameters within the nanometer-scale and the core-shell structure of the composite fibers was clearly confirmed by TEM. Additionally, fiber alignment significantly increased (>2-fold) the elastic modulus of both coaxial and monoxial scaffolds. Kartogenin (KGN), a small molecule known to promote mesenchymal stem/stromal cells (MSC) chondrogenesis, was loaded into the core PGS solution to generate coaxial PGS-KGN/PCL nanofibers. The KGN release kinetics and scaffold biological performance were evaluated in comparison to KGN-loaded monoaxial fibers and respective non-loaded controls. Coaxial PGS-KGN/PCL nanofibers showed a more controlled and sustained KGN release over 21 days than monoaxial PCL-KGN nanofibers. When cultured with human bone marrow MSC in incomplete chondrogenic medium (without TGF-ß3), KGN-loaded scaffolds enhanced significantly cell proliferation and chondrogenic differentiation, as suggested by the increased sGAG amounts and chondrogenic markers gene expression levels. Overall, these findings highlight the potential of using coaxial PGS-KGN/PCL aligned nanofibers as a bioactive scaffold for CTE applications.
Assuntos
Anilidas , Cartilagem , Nanofibras/química , Ácidos Ftálicos , Engenharia Tecidual , Alicerces Teciduais , Anilidas/química , Anilidas/metabolismo , Anilidas/farmacocinética , Anilidas/farmacologia , Cartilagem/citologia , Cartilagem/metabolismo , Proliferação de Células/efeitos dos fármacos , Células Cultivadas , Decanoatos/química , Técnicas Eletroquímicas , Desenho de Equipamento , Glicerol/análogos & derivados , Glicerol/química , Humanos , Células-Tronco Mesenquimais/efeitos dos fármacos , Ácidos Ftálicos/química , Ácidos Ftálicos/metabolismo , Ácidos Ftálicos/farmacocinética , Ácidos Ftálicos/farmacologia , Poliésteres/química , Polímeros/química , Engenharia Tecidual/instrumentação , Engenharia Tecidual/métodosRESUMO
Bisphenols and phthalates leach from medical devices, and this exposure is likely to increase in postcardiac surgery patients. Previous studies suggest that such chemical exposure may impact recovery and wound healing, yet the direct effects of bisphenols and phthalates are unknown in this context. To study the direct effect of clinically based chemical exposures, we measured the metabolites representative of 6 bisphenols and 10 phthalates in men before and after cardiac surgery and then replicated this exposure in a mouse model of cardiac surgery and assessed survival, cardiac function and inflammation. Bisphenol A (BPA), di-ethyl hexyl phthalate (DEHP), butylbenzyl phthalate, di-isodecyl phthalate, and di-n-butyl phthalate metabolites were increased after surgery. DEHP exposure predominated, was positively correlated with duration on the cardiopulmonary bypass machine and exceeded its tolerable daily intake limit by 37-fold. In vivo, C57bl/6 N male mice treated with BPA+phthalates during recovery from surgery-induced myocardial infarction had reduced survival, greater cardiac dilation, reduced cardiac function and increased infiltration of neutrophils, monocytes and macrophages suggesting impaired recovery. Of interest, genetic ablation or estrogen receptor beta (ERß) antagonism did not improve recovery and replacement of DEHP with tri-octyl trimellitate or removal of BPA from the mixture did not ameliorate these effects. To examine the direct effects on inflammation, treatment of human THP-1 macrophages with BPA and phthalates induced a dysfunctional proinflammatory macrophage phenotype with increased expression of M1-type macrophage polarization markers and MMP9 secretion, yet reduced phagocytic activity. These results suggest that chemicals escape from medical devices and may impair patient recovery.
Assuntos
Compostos Benzidrílicos/toxicidade , Procedimentos Cirúrgicos Cardíacos/instrumentação , Equipamentos e Provisões , Infarto do Miocárdio/fisiopatologia , Fenóis/toxicidade , Ácidos Ftálicos/toxicidade , Idoso , Animais , Compostos Benzidrílicos/farmacocinética , Compostos Benzidrílicos/intoxicação , Compostos Benzidrílicos/urina , Quimiocina CCL2/metabolismo , Dibutilftalato/farmacocinética , Dibutilftalato/toxicidade , Dietilexilftalato/farmacocinética , Dietilexilftalato/intoxicação , Dietilexilftalato/toxicidade , Poluentes Ambientais/toxicidade , Receptor beta de Estrogênio/deficiência , Receptor beta de Estrogênio/metabolismo , Humanos , Macrófagos/efeitos dos fármacos , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Pessoa de Meia-Idade , Fenóis/farmacocinética , Fenóis/intoxicação , Fenóis/urina , Ácidos Ftálicos/metabolismo , Ácidos Ftálicos/farmacocinética , Ácidos Ftálicos/intoxicação , Ácidos Ftálicos/urina , Células THP-1 , Cicatrização/efeitos dos fármacosRESUMO
A scaffold composed of different collagen (COL)/chitosan (CS)/hyaluronic acid sodium (HAS) salt ratios was evaluated by determining porosity, swelling, loss rate in hot water, mechanical property, and cell proliferation to obtain optimum conditions for manufacturing porous scaffolds. Results showed that the optimal ratio of COL/CS/HAS salt porous scaffold was 1:1:0.1. High swelling and loss rate of scaffolds/microspheres (MPs) could lead to high diffusion rate of MPs from the scaffolds, causing an increase in the kartogenin (KGN) release. The porous scaffolds at optimum conditions had a maximum amount of KGN release. Results of in vitro fluorescence staining and cell proliferation suggested that scaffolds/MPs had good biocompatibility and the capability to promote bone marrow stromal cell proliferation, cartilage tissue regeneration, and integration between the repaired and surrounding cartilages. Therefore, this composite could be a promising material for cartilage repair and regeneration, which could be effective in the knee osteoarthritis treatment.
Assuntos
Anilidas , Células da Medula Óssea/metabolismo , Colágeno , Células-Tronco Mesenquimais/metabolismo , Microesferas , Ácidos Ftálicos , Engenharia Tecidual , Anilidas/química , Anilidas/farmacocinética , Anilidas/farmacologia , Animais , Células da Medula Óssea/citologia , Colágeno/química , Colágeno/farmacocinética , Colágeno/farmacologia , Preparações de Ação Retardada/química , Preparações de Ação Retardada/farmacocinética , Preparações de Ação Retardada/farmacologia , Humanos , Células-Tronco Mesenquimais/citologia , Camundongos , Ácidos Ftálicos/química , Ácidos Ftálicos/farmacocinética , Ácidos Ftálicos/farmacologia , PorosidadeRESUMO
Partly PEGylated polyamidoamine (PAMAM) dendrimer was used as the nanocarrier for the cytoplasmic delivery of kartogenin (KGN) to induce chondrogenic differentiation of mesenchymal stem cells (MSCs). Here, KGN was conjugated to the surface of PAMAM and the end group of polyethylene glycol (PEG) to obtain PEG-PAMAM-KGN (PPK) and KGN-PEG-PAMAM (KPP) conjugate, respectively. The effects of PPK and KPP on the in vitro chondrogenic differentiation of MSCs were evaluated. KPP induced higher expression of chondrogenic markers than PPK and free KGN. In particular, after treatment of KPP, CBF ß nuclear localization intensity was significantly increased, indicating enhanced efficacy of chondrogenesis. The fluorescein labeled PEG-PAMAM was capable to persist in the joint cavity for a prolonged time of both healthy and osteoarthritis (OA) rats. Thus, PEG-PAMAM could be a useful nanocarrier for intra-articular (IA) delivery of drug to treat OA.
Assuntos
Anilidas/administração & dosagem , Condrogênese/efeitos dos fármacos , Dendrímeros/química , Portadores de Fármacos/química , Células-Tronco Mesenquimais/efeitos dos fármacos , Ácidos Ftálicos/administração & dosagem , Polietilenoglicóis/química , Anilidas/farmacocinética , Anilidas/farmacologia , Animais , Diferenciação Celular/efeitos dos fármacos , Células Cultivadas , Células-Tronco Mesenquimais/citologia , Osteoartrite/tratamento farmacológico , Ácidos Ftálicos/farmacocinética , Ácidos Ftálicos/farmacologia , RatosRESUMO
UNLABELLED: Dual drug delivery of drugs with different therapeutic effects in a single system is an effective way to treat a disease. One of the main challenges in dual drug delivery is to control the release behavior of each drug independently. In this study, we devised thermo-responsive polymeric nanospheres that can provide simultaneous and independent dual drug delivery in the response to temperature change. The nanospheres based on chitosan oligosaccharide conjugated pluronic F127 grafting carboxyl group were synthesized to deliver kartogenin (KGN) and diclofenac (DCF) in a single system. To achieve the dual drug release, KGN was covalently cross-linked to the outer part of the nanosphere, and DCF was loaded into the inner core of the nanosphere. The nanospheres demonstrated immediate release of DCF and sustained release of KGN, which were independently controlled by temperature change. The nanospheres treated with cold temperature effectively suppressed lipopolysaccharide-induced inflammation in chondrocytes and macrophage-like cells. The nanospheres also induced chondrogenic differentiation of mesenchymal stem cells, which was further enhanced by cold shock treatment. Bioluminescence of the fluorescence-labeled nanospheres was significantly increased after cold treatment in vivo. The nanospheres suppressed the progression of osteoarthritis in treated rats, which was further enhanced by cold treatment. The nanospheres also reduced cyclooxygenase-2 expression in the serum and synovial membrane of treated rats, which were further decreased with cold treatment. These results suggest that the thermo-responsive nanospheres provide dual-function therapeutics possessing anti-inflammatory and chondroprotective effects which can be enhanced by cold treatment. STATEMENT OF SIGNIFICANCE: We developed thermo-responsive nanospheres that can provide a useful dual-function of suppressing the inflammation and promoting chondrogenesis in the treatment of osteoarthritis. For a dual delivery system to be effective, the release behavior of each drug should be independently controlled to optimize their desired therapeutic effects. We employed rapid release of diclofenac for acute anti-inflammatory effects, and sustained release of kartogenin, a newly found molecule, for chondrogenic effects in this polymeric nanospheres. This nanosphere demonstrated immediate release of diclofenac and sustained release of kartogenin, which were independently controlled by temperature change. The effectiveness of this system to subside inflammation and regenerate cartilage in osteoarthritis was successful demonstrated through in vitro and in vivo experiments in this study. We think that this study will add a new concept to current body of knowledge in the field of drug delivery and treatment of osteoarthritis.
Assuntos
Anilidas , Diclofenaco , Portadores de Fármacos , Nanosferas , Osteoartrite/tratamento farmacológico , Ácidos Ftálicos , Anilidas/química , Anilidas/farmacocinética , Anilidas/farmacologia , Diferenciação Celular/efeitos dos fármacos , Quitosana/química , Quitosana/farmacocinética , Quitosana/farmacologia , Condrócitos/metabolismo , Condrócitos/patologia , Diclofenaco/química , Diclofenaco/farmacocinética , Diclofenaco/farmacologia , Portadores de Fármacos/química , Portadores de Fármacos/farmacocinética , Portadores de Fármacos/farmacologia , Feminino , Humanos , Macrófagos/metabolismo , Macrófagos/patologia , Masculino , Células-Tronco Mesenquimais/metabolismo , Células-Tronco Mesenquimais/patologia , Pessoa de Meia-Idade , Nanosferas/química , Nanosferas/uso terapêutico , Oligossacarídeos/química , Oligossacarídeos/farmacocinética , Oligossacarídeos/farmacologia , Osteoartrite/metabolismo , Osteoartrite/patologia , Ácidos Ftálicos/química , Ácidos Ftálicos/farmacocinética , Ácidos Ftálicos/farmacologia , Poloxâmero/química , Poloxâmero/farmacocinéticaRESUMO
Chronic obstructive pulmonary disease (COPD) is a progressive lung disease associated with significant morbidity and mortality. Although several oral phosphodiesterase 4 (PDE4) inhibitors have been developed for the treatment of COPD, their use has been restricted because of side effects including nausea and emesis. We hypothesized that delivery of a dry powdered PDE4 inhibitor by inhalation would minimize systemic absorption and enable local PDE4 inhibition to suppress inflammation within the lung. Neutrophilic pulmonary inflammation was induced in mice by intratracheal administration of lipopolysaccharide. Mice were treated intratracheally with a new dry powder PDE4 inhibitor, E6005 (methyl 4-[({3-[6,7-dimethoxy-2-(methylamino)quinazolin-4-yl]phenyl}amino) carbonyl] benzoate). The pharmacokinetics, cell profiles and levels of cytokines, chemokines, and lipid mediators in bronchoalveolar lavage fluid (BALF), and lung histology were assessed. Intratracheal administration of E6005 to mice resulted in high concentrations of the compound in the lungs. Histological analysis of E6005-treated mice demonstrated reduced inflammation of lung tissue that correlated with a decrease in BALF levels of neutrophils, proinflammatory cytokines, chemokines, and cysteinyl leukotrienes. Thus, intratracheal administration of E6005 effectively suppresses neutrophilic pulmonary inflammation, suggesting that the new inhaled dry powder PDE4 inhibitor represents an alternative to the conventional oral formulation for treating COPD.
Assuntos
Inibidores da Fosfodiesterase 4/administração & dosagem , Inibidores da Fosfodiesterase 4/farmacologia , Ácidos Ftálicos/administração & dosagem , Ácidos Ftálicos/farmacologia , Pneumonia/tratamento farmacológico , Quinazolinas/administração & dosagem , Quinazolinas/farmacologia , Administração por Inalação , Animais , Líquido da Lavagem Broncoalveolar , Quimiocinas/metabolismo , Feminino , Metabolismo dos Lipídeos/efeitos dos fármacos , Lipopolissacarídeos/farmacologia , Pulmão/efeitos dos fármacos , Pulmão/metabolismo , Pulmão/patologia , Camundongos , Camundongos Endogâmicos C57BL , Inibidores da Fosfodiesterase 4/farmacocinética , Inibidores da Fosfodiesterase 4/uso terapêutico , Ácidos Ftálicos/farmacocinética , Ácidos Ftálicos/uso terapêutico , Pneumonia/induzido quimicamente , Pneumonia/metabolismo , Pneumonia/patologia , Quinazolinas/farmacocinética , Quinazolinas/uso terapêuticoRESUMO
Sodium-dependent high-affinity amino-acid transporters play crucial roles in terminating synaptic transmission in the central nervous system (CNS). However, there is lack of information about the mechanisms underlying the regulation of amino-acid transport by fast-acting neuromodulators, like ATP. Here, we investigated whether activation of the ATP-sensitive P2X7 receptor modulates Na(+)-dependent high-affinity γ-aminobutyric acid (GABA) and glutamate uptake into nerve terminals (synaptosomes) of the rat cerebral cortex. Radiolabeled neurotransmitter accumulation was evaluated by liquid scintillation spectrometry. The cell-permeant sodium-selective fluorescent indicator, SBFI-AM, was used to estimate Na(+) influx across plasma membrane. 2'(3')-O-(4-benzoylbenzoyl)ATP (BzATP, 3-300 µM), a prototypic P2X7 receptor agonist, concentration-dependently decreased [(3)H]GABA (14%) and [(14)C]glutamate (24%) uptake; BzATP decreased transport maximum velocity (Vmax) without affecting the Michaelis constant (Km) values. The selective P2X7 receptor antagonist, A-438079 (3 µM), prevented inhibition of [(3)H]GABA and [(14)C]glutamate uptake by BzATP (100 µM). The inhibitory effect of BzATP coincided with its ability to increase intracellular Na(+) and was mimicked by Na(+) ionophores, like gramicidin and monensin. Increases in intracellular Na(+) (with veratridine or ouabain) or substitution of extracellular Na(+) by N-methyl-D-glucamine (NMDG)(+) all decreased [(3)H]GABA and [(14)C]glutamate uptake and attenuated BzATP effects. Uptake inhibition by BzATP (100 µM) was also attenuated by calmidazolium, which selectively inhibits Na(+) currents through the P2X7 receptor pore. In conclusion, disruption of the Na(+) gradient by P2X7 receptor activation downmodulates high-affinity GABA and glutamate uptake into rat cortical synaptosomes. Interference with amino-acid transport efficacy may constitute a novel target for therapeutic management of cortical excitability.
Assuntos
Sistemas de Transporte de Aminoácidos Acídicos/farmacocinética , Córtex Cerebral/metabolismo , Ácido Glutâmico/farmacocinética , Receptores Purinérgicos P2X7/metabolismo , Sinaptossomos/metabolismo , Ácido gama-Aminobutírico/farmacocinética , Trifosfato de Adenosina/análogos & derivados , Trifosfato de Adenosina/farmacologia , Sistemas de Transporte de Aminoácidos Acídicos/efeitos dos fármacos , Animais , Benzofuranos/farmacocinética , Radioisótopos de Carbono , Córtex Cerebral/diagnóstico por imagem , Córtex Cerebral/efeitos dos fármacos , Feminino , Masculino , Ácidos Ftálicos/farmacocinética , Agonistas do Receptor Purinérgico P2X/farmacologia , Antagonistas do Receptor Purinérgico P2X/farmacologia , Piridinas/farmacologia , Cintilografia , Ratos , Ratos Wistar , Sódio/metabolismo , Sinaptossomos/diagnóstico por imagem , Sinaptossomos/efeitos dos fármacos , Tetrazóis/farmacologia , TrítioRESUMO
Phthalates may be present in food due to their widespread presence as environmental contaminants or due to migration from food contact materials. Exposure to phthalates is considered to be potentially harmful to human health as well. Therefore, determining the main source of exposure is an important issue. So, the purpose of this study was (1) to measure the release of diethyl phthalate (DEP) in bottled water consumed in common storage conditions specially low temperature and freezing conditions; (2) to evaluate the intake of DEP from polyethylene terephthalate (PET) bottled water and health risk assessment; and (3) to assess the contribution of the bottled water to the DEP intake against the tolerable daily intake (TDI) values. DEP migration was investigated in six brands of PET-bottled water under different storage conditions room temperature, refrigerator temperature, freezing conditions (40 °C ,0 °C and -18 °C) and outdoor] at various time intervals by magnetic solid extraction (MSPE) using gas chromatography-mass spectroscopy (GC-MS). Eventually, a health risk assessment was conducted and the margin of exposure (MOE) was calculated. The results indicate that contact time with packaging and storage temperatures caused DEP to be released into water from PET bottles. But, when comprising the DEP concentration with initial level, the results demonstrated that the release of phthalates were not substantial in all storage conditions especially at low temperatures (<25 °C) and freezing conditions. The daily intake of DEP from bottled water was much lower than the reference value. However, the lowest MOE was estimated for high water consumers (preschooler > children > lactating women > teenagers > adults > pregnant women), but in all target groups, the MOE was much higher than 1000, thus, low risk is implied. Consequently, PET-bottled water is not a major source of human exposure to DEP and from this perspective is safe for consumption.
Assuntos
Água Potável/química , Exposição Ambiental/análise , Ácidos Ftálicos/análise , Polietilenotereftalatos/química , Poluentes Químicos da Água/análise , Adulto , Criança , Ingestão de Líquidos/fisiologia , Água Potável/normas , Feminino , Cromatografia Gasosa-Espectrometria de Massas , Humanos , Irã (Geográfico) , Lactação/metabolismo , Neoplasias/epidemiologia , Nível de Efeito Adverso não Observado , Ácidos Ftálicos/farmacocinética , Ácidos Ftálicos/toxicidade , Medição de Risco , Poluentes Químicos da Água/farmacocinética , Poluentes Químicos da Água/toxicidadeRESUMO
Men are at risk of becoming completely infertile due to innumerable environmental chemicals and pollutants. These xenobiotics, hence, should be tested for their potential adverse effects on male fertility. However, the testing load, a monumental challenge for employing conventional animal models, compels the pursuit of alternative models. Towards this direction, we show here that Drosophila melanogaster, an invertebrate, with its well characterized/conserved male reproductive processes/proteome, recapitulates male reproductive toxicity phenotypes observed in mammals when exposed to a known reproductive toxicant, dibutyl phthalate (DBP). Analogous to mammals, exposure to DBP reduced fertility, sperm counts, seminal proteins, increased oxidative modification/damage in reproductive tract proteins and altered the activity of a hormone receptor (estrogen related receptor) in Drosophila males. In addition, we show here that DBP is metabolized to monobutyl phthalate (MBP) in exposed Drosophila males and that MBP is more toxic than DBP, as observed in higher organisms. These findings suggest Drosophila as a potential alternative to traditional animal models for the prescreening of chemicals for their reproductive adversities and also to gain mechanistic insights into chemical-mediated endocrine disruption and male infertility.
Assuntos
Dibutilftalato/toxicidade , Drosophila melanogaster/efeitos dos fármacos , Poluentes Ambientais/toxicidade , Infertilidade Masculina/induzido quimicamente , Ácidos Ftálicos/toxicidade , Xenobióticos/toxicidade , Animais , Dibutilftalato/farmacocinética , Drosophila melanogaster/crescimento & desenvolvimento , Drosophila melanogaster/metabolismo , Poluentes Ambientais/farmacocinética , Fertilidade/efeitos dos fármacos , Fertilidade/genética , Infertilidade Masculina/genética , Infertilidade Masculina/patologia , Masculino , Microscopia Confocal , Ácidos Ftálicos/farmacocinética , Reprodução/efeitos dos fármacos , Reprodução/genética , Contagem de Espermatozoides , Espermatozoides/efeitos dos fármacos , Espermatozoides/metabolismo , Espermatozoides/patologia , Transcriptoma/efeitos dos fármacos , Xenobióticos/farmacocinéticaRESUMO
Phthalates are chemicals widely used in industry and the consequences for human health caused by exposure to these agents are of significant current interest. Phthalate toxicity targets the reproductive and respiratory systems primarily, but they also may be involved in the processes of carcinogenesis and even in autism spectrum disorders. This article discusses the molecular and cellular mechanisms involved in organ toxicity of phthalates; furthermore, pharmacokinetic, chemistry and the European regulation are summarized.
Assuntos
Poluentes Ambientais/toxicidade , Ácidos Ftálicos/toxicidade , Animais , Qualidade de Produtos para o Consumidor/legislação & jurisprudência , Poluentes Ambientais/farmacocinética , Europa (Continente) , Regulamentação Governamental , Humanos , Ácidos Ftálicos/farmacocinéticaRESUMO
With structural guidance, tropane-derived HTS hits were modified to optimize for HSP90 inhibition and a desirable in vivo profile. Through an iterative SAR development process 12i (XL888) was discovered and shown to reduce HSP90 client protein content in PD studies. Furthermore, efficacy experiments performed in a NCI-N87 mouse xenograft model demonstrated tumor regression in some dosing regimens.
Assuntos
Antineoplásicos/química , Antineoplásicos/uso terapêutico , Compostos Azabicíclicos/química , Compostos Azabicíclicos/uso terapêutico , Proteínas de Choque Térmico HSP90/antagonistas & inibidores , Neoplasias/tratamento farmacológico , Ácidos Ftálicos/química , Ácidos Ftálicos/uso terapêutico , Animais , Antineoplásicos/farmacocinética , Antineoplásicos/farmacologia , Compostos Azabicíclicos/farmacocinética , Compostos Azabicíclicos/farmacologia , Linhagem Celular Tumoral , Proliferação de Células/efeitos dos fármacos , Cristalografia por Raios X , Descoberta de Drogas , Proteínas de Choque Térmico HSP90/metabolismo , Humanos , Camundongos , Modelos Moleculares , Neoplasias/metabolismo , Neoplasias/patologia , Ácidos Ftálicos/farmacocinética , Ácidos Ftálicos/farmacologiaRESUMO
PURPOSE: Diisononyl phthalate (DiNP) is primarily used as a plasticizer in polyvinyl chloride (PVC) materials. While information is available on general population exposure to DiNP, occupational exposure data are lacking. We present DiNP metabolite urinary concentrations in PVC processing workers, estimate DiNP daily intake for these workers, and compare worker estimates to other populations. METHODS: We assessed DiNP exposure in participants from two companies that manufactured PVC materials, a PVC film manufacturer (n = 25) and a PVC custom compounder (n = 12). A mid-shift and end-shift urine sample was collected from each participant and analyzed for the DiNP metabolite mono(carboxy-isooctyl) phthalate (MCiOP). Mixed models were used to assess the effect on MCiOP concentrations of a worker being assigned to (1) a task using DiNP and (2) a shift where DiNP was used. A simple pharmacokinetic model was used to estimate DiNP daily intake from the MCiOP concentrations. RESULTS: Creatinine-adjusted MCiOP urinary concentrations ranged from 0.42-80 µg/g in PVC film and from 1.11-13.4 µg/g in PVC compounding. PVC film participants who worked on a task using DiNP (n = 7) had the highest MCiOP geometric mean (GM) end-shift concentration (25.2 µg/g), followed by participants who worked on a shift where DiNP was used (n = 11) (17.7 µg/g) as compared to participants with no task (2.92 µg/g) or shift (2.08 µg/g) exposure to DiNP. The GM end-shift MCiOP concentration in PVC compounding participants (4.80 µg/g) was comparable to PVC film participants with no task or shift exposure to DiNP. Because no PVC compounding participants were assigned to tasks using DINP on the day sampled, DiNP exposure in this company may be underestimated. The highest DiNP intake estimate was 26 µg/kg/day. CONCLUSION: Occupational exposure to DiNP associated with PVC film manufacturing tasks were substantially higher (sixfold to tenfold) than adult general population exposures; however, all daily intake estimates were less than 25% of current United States or European acceptable or tolerable daily intake estimates. Further characterization of DiNP occupational exposures in other industries is recommended.
Assuntos
Indústria Química , Exposição Ocupacional/análise , Ácidos Ftálicos/farmacocinética , Cloreto de Polivinila , Adolescente , Adulto , Biomarcadores/urina , Monitoramento Ambiental , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Ácidos Ftálicos/urina , Adulto JovemRESUMO
Polyethylene terephthalate, a copolymer of terephthalic acid (TPA) or dimethyl terephthalate (DMT) with ethylene glycol, has food, beverage, and drinking water contact applications. Di-2-ethylhexyl terephthalate (DEHT) is a plasticizer in food and drinking water contact materials. Oral reference doses (RfDs) and total allowable concentrations (TACs) in drinking water were derived for TPA, DMT, and DEHT. Category RfD and TAC levels were also established for nine C(1)-C(8) terephthalate esters. The mode of action of TPA, and of DMT, which is metabolized to TPA, involves urinary acidosis, altered electrolyte elimination and hypercalciuria, urinary supersaturation with calcium terephthalate or calcium hydrogen terephthalate, and crystallization into bladder calculi. Weanling rats were more sensitive to calculus formation than dams. Calculi-induced irritation led to bladder hyperplasia and tumors in rats fed 1000 mg/kg-day TPA. The lack of effects at 142 mg/kg-day supports a threshold for urine saturation with calcium terephthalate, a key event for calculus formation. Chronic dietary DMT exposure in rodents caused kidney inflammation, but not calculi. Chronic dietary DEHT exposure caused general toxicity unrelated to calculi, although urine pH was reduced suggesting the TPA metabolite was biologically-active, but of insufficient concentration to induce calculi. Respective oral reference doses of 0.5, 0.5, and 0.2 mg/kg-day and total allowable drinking water concentrations of 3, 3, and 1 mg/L were derived for TPA, DMT, and DEHT. An oral RfD of 0.2 mg/kg-day for the terephthalate category chemicals corresponded to a drinking water TAC of 1 mg/L.
Assuntos
Poluentes Ambientais/toxicidade , Ácidos Ftálicos/toxicidade , Testes de Toxicidade , Absorção , Administração Oral , Animais , Relação Dose-Resposta a Droga , Poluentes Ambientais/química , Poluentes Ambientais/farmacocinética , Ésteres , Humanos , Taxa de Depuração Metabólica , Estrutura Molecular , Ácidos Ftálicos/química , Ácidos Ftálicos/farmacocinética , Medição de Risco , Especificidade da Espécie , Distribuição TecidualRESUMO
The constantly evolving science of risk assessment is currently faced with many challenges, not only from the interpretation of the volume of data being generated with new innovative technologies, but also in attempting to quantitatively incorporate this information into understanding potential risk of adverse events in human populations. The objective of the case study described was to use the more recent data for di-(2-ethylhexyl)phthalate (DEHP) to investigate the impact of innovative quantitative approaches on the risk assessment of a compound, specifically as it can be used to move towards the new vision of risk assessment involving the integration of the available toxicological data to understand underlying biological processes. What emerged were several outcomes that demonstrated clearly the importance of the integration of the toxicological data, specifically to understand the biological processes being impacted, because standard statistical modeling approaches may not be adequate to describe the dose-response relationships observed. Alternative approaches demonstrate that a definitive mode of action is not needed to justify the shape of the low-dose region or a threshold, when the integration of the available data assist risk assessors in understanding the shape of the dose-response curve for both noncancer and cancer endpoints. Many of the challenges described as part of this case study would likely be encountered with compounds other than DEHP, especially other receptor-mediated compounds or compounds that "perturb" biological pathways, such as endocrine disruptors. This case study also highlights the importance of communication between risk assessors and the research community to focus on the generation of data most relevant for assessing the potential for chemicals to impact biological systems in the human.
Assuntos
Ácidos Ftálicos/toxicidade , Medição de Risco/métodos , Administração por Inalação , Administração Oral , Animais , Relação Dose-Resposta a Droga , Feminino , Humanos , Masculino , Ácidos Ftálicos/metabolismo , Ácidos Ftálicos/farmacocinética , Ratos , Toxicologia/métodosRESUMO
Although, it is well-established that information on the metabolism of a substance is important in the evaluation of its toxic potential, there is limited experience with incorporating metabolic aspects into in vitro tests for endocrine disrupters. The aim of the current study was a) to study different in vitro systems for biotransformation of ten known endocrine disrupting chemicals (EDs): five azole fungicides, three parabens and 2 phthalates, b) to determine possible changes in the ability of the EDs to bind and activate the thyroid receptor (TR) in the in vitro T-screen assay after biotransformation and c) to investigate the endogenous metabolic capacity of the GH3 cells, the cell line used in the T-screen assay, which is a proliferation assay used for the in vitro detection of agonistic and antagonistic properties of compounds at the level of the TR. The two in vitro metabolizing systems tested the human liver S9 mix and the PCB-induced rat microsomes gave an almost complete metabolic transformation of the tested parabens and phthalates. No marked difference the effects in the T-screen assay was observed between the parent compounds and the effects of the tested metabolic extracts. The GH3 cells themselves significantly metabolized the two tested phthalates dimethyl phthalate (DMP) and diethyl phthalate (DEP). Overall the results and qualitative data from the current study show that an in vitro metabolizing system using liver S9 or microsomes could be a convenient method for the incorporation of metabolic and toxicokinetic aspects into in vitro testing for endocrine disrupting effects.
Assuntos
Antifúngicos/farmacocinética , Disruptores Endócrinos/farmacocinética , Fungicidas Industriais/farmacocinética , Receptores dos Hormônios Tireóideos/metabolismo , Animais , Azóis/farmacocinética , Bioensaio , Biotransformação , Linhagem Celular , Linhagem Celular Tumoral , Humanos , Técnicas In Vitro , Microssomos Hepáticos/efeitos dos fármacos , Microssomos Hepáticos/metabolismo , Parabenos/farmacocinética , Ácidos Ftálicos/farmacocinética , RatosRESUMO
Proteomic changes in proteins secreted by human hepatocellular carcinomas (HepG2) cells exposed to butyl benzyl phthalate (BBP) were evaluated. HepG2 cells were treated with three different concentrations of BBP (0, 10, or 25 µM) for 24 or 48 h. Following incubation, the cells were subjected to proteomic analysis using two different pI ranges (4-7 and 6-9) and large-size two-dimensional gel electrophoresis. Results showed resolution of a total of 2776 protein spots. Of these, 29, including 19 upregulated and 10 downregulated proteins, were identified by electrospray ionization-mass spectrometry-mass spectrometry (ESI-MS/MS). Among these, the identities of cystatin C, Rho guanine nucleotide dissociation inhibitor, gelsolin, DEK protein, Raf kinase inhibitory protein, triose phosphate isomerase, heptaglobin-related protein, inter-alpha-trypsin inhibitor heavy chain H2, and electron transfer flavoprotein subunit beta were confirmed by Western blot analysis. These proteins were found to be involved in apoptosis, signaling, tumor progression, energy metabolism, and cell structure and motility. Therefore, these proteins have potential to be employed as biomarkers of BBP exposure and may be useful in understanding mechanisms underlying the adverse effects of BBP.
Assuntos
Células Hep G2/efeitos dos fármacos , Neoplasias Hepáticas/metabolismo , Ácidos Ftálicos/toxicidade , Proteoma/análise , Teratogênicos/toxicidade , Animais , Biomarcadores Tumorais/metabolismo , Western Blotting , Sobrevivência Celular/efeitos dos fármacos , Ensaio Cometa , Dano ao DNA , Eletroforese em Gel Bidimensional , Formazans/metabolismo , Células Hep G2/metabolismo , Humanos , Focalização Isoelétrica , Neoplasias Hepáticas/química , Masculino , Análise em Microsséries , Mapeamento de Peptídeos , Ácidos Ftálicos/farmacocinética , Proteômica , Ratos , Ratos Sprague-Dawley , Coloração pela Prata , Espectrometria de Massas por Ionização por Electrospray , Espectrometria de Massas em Tandem , Teratogênicos/farmacocinética , Sais de Tetrazólio/metabolismoRESUMO
BACKGROUND: Phthalates are known to have estrogenic effects in cell models and experimental animals. However, the evidence regarding the effects of phthalates on human reproduction is still limited. We conducted a case-control study to determine whether estrogen-dependent diseases are associated with phthalate exposure and how the glutathione S-transferase M1 (GSTM1; a major detoxification enzyme) genotype modulates the risk. METHODS: We recruited subjects who underwent laparotomy and had pathologic confirmation of endometriosis (EN) (n = 28), adenomyosis (AD) (n = 16) and leiomyoma (LEI) (n = 36) from the Department of Obstetrics and Gynecology at a medical center in Taiwan between 2005 and 2007. Controls (n = 29) were patients without any of the three aforementioned gynecologic conditions. Urine samples were collected before surgery and analyzed for seven phthalate metabolites using liquid chromatography-tandem mass spectrometry. Peripheral lymphocytes were used for GSTM1 genotype determination. RESULTS: Patients with LEIs had significantly higher levels of total urinary mono-ethylhexyl phthalate (SigmaMEHP; 52.1 versus 18.9 microg/g creatinine, P < 0.05) than the controls, whereas patients with EN had an increased level of urinary mono-n-butyl phthalate (94.1 versus 58.0 microg/g creatinine, P < 0.05). Subjects with GSTM1 null genotype had significantly increased odds for AD relative to those with GSTM1 wild genotype [odds ratio (OR) = 5.30; 95% CI, 1.22-23.1], even after adjustment for age and phthalate exposure. Subjects who carried the GSTM1 null genotype and had a high urinary level of SigmaMEHP showed a significantly increased risk for AD (OR = 10.4; 95% CI, 1.26-85.0) and LEIs (OR = 5.93; 95% CI, 1.10-31.9) after adjustment for age, compared with those with GSTM1 wild-type and low urinary level of SigmaMEHP. CONCLUSIONS: These results suggest that both GSTM1 null and phthalate exposure are associated with AD and LEI. Larger studies are warranted to investigate potential interaction between GSTM1 null and phthalate exposure in the etiology of estrogen-dependent gynecologic conditions.
Assuntos
Endometriose/etiologia , Glutationa Transferase/genética , Leiomioma/etiologia , Ácidos Ftálicos/toxicidade , Neoplasias Uterinas/etiologia , Adulto , Sequência de Bases , Estudos de Casos e Controles , Primers do DNA/genética , Endometriose/enzimologia , Endometriose/genética , Exposição Ambiental , Feminino , Genótipo , Humanos , Inativação Metabólica , Leiomioma/enzimologia , Leiomioma/genética , Pessoa de Meia-Idade , Neoplasias Hormônio-Dependentes/enzimologia , Neoplasias Hormônio-Dependentes/etiologia , Neoplasias Hormônio-Dependentes/genética , Ácidos Ftálicos/farmacocinética , Polimorfismo Genético , Fatores de Risco , Neoplasias Uterinas/enzimologia , Neoplasias Uterinas/genéticaRESUMO
Proteasome inhibition is a new strategy in cancer therapy. We synthesized three new peptide aldehyde inhibitors linked to the benzamide derivative structure to use their cytotoxic activity against malignant melanoma cells. Of these, 10 displayed the highest cytotoxicity (0.18 +/- 0.16 microM). A radiosynthesis of the iodine aldehyde was performed. Its drug biodistribution showed that some selectivity of the benzamide group toward malignant melanoma tissue was conserved.
Assuntos
Antineoplásicos/síntese química , Benzamidas/síntese química , Oligopeptídeos/síntese química , Ácidos Ftálicos/síntese química , Inibidores de Proteassoma , Compostos Radiofarmacêuticos/síntese química , Triazenos/síntese química , Animais , Antineoplásicos/farmacocinética , Antineoplásicos/farmacologia , Benzamidas/farmacocinética , Benzamidas/farmacologia , Linhagem Celular Tumoral , Ensaios de Seleção de Medicamentos Antitumorais , Humanos , Radioisótopos do Iodo , Leucina/análogos & derivados , Leucina/síntese química , Leucina/farmacocinética , Leucina/farmacologia , Melanoma Experimental/metabolismo , Camundongos , Transplante de Neoplasias , Oligopeptídeos/farmacocinética , Oligopeptídeos/farmacologia , Ácidos Ftálicos/farmacocinética , Ácidos Ftálicos/farmacologia , Compostos Radiofarmacêuticos/farmacocinética , Compostos Radiofarmacêuticos/farmacologia , Estereoisomerismo , Distribuição Tecidual , Transplante Heterólogo , Triazenos/farmacocinética , Triazenos/farmacologiaRESUMO
The rat has been explored in detail for its in utero susceptibility to male reproductive tract malformation following phthalate exposure. Few other species have been studied in detail, and it is important for both mechanistic and risk assessment purposes to understand the species specificity of this response. We investigated the response of the fetal mouse testis to phthalate exposure and compared these results with those previously obtained from the rat. Initial experiments using a variety of phthalate congeners (monobutyl phthalate, di-(n-butyl) phthalate, or mono (2-ethylhexyl) phthalate) and exposure paradigms did not reduce fetal mouse testis testosterone levels. Pharmacokinetic data after a single 500 mg/kg di-(n-butyl)-phthalate (DBP) exposure on mouse gestation day (gd) 18 demonstrated that the concentrations and kinetics of the active metabolite monobutyl phthalate (MBP) in fetal and maternal plasma were similar to the rat. After a single 500 mg/kg or multiple day 250 mg/kg fetal mouse DBP exposure, rapid and dynamic changes in testis gene expression were observed, including induction of immediate early genes. Unlike the rat, expression of genes involved in cholesterol homeostasis and steroidogenesis were not decreased and were increased in a few cases. Similar to the rat, however, a 250- or 500-mg DBP/kg/day mouse exposure from gd 16 through 18 significantly increased seminiferous cord diameter, the number of multinucleated gonocytes per cord, and the number of nuclei per multinucleated gonocyte. Together, these results demonstrate that fetal mouse and rat phthalate exposure both induce immediate early gene expression and disrupt seminiferous cord and gonocyte development. This response in the mouse occurs without a measurable decrease in testicular testosterone, suggesting that altered seminiferous cord formation and gonocyte multinucleation may not be mechanistically linked to lowered testosterone.